Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Peck-Radosavljevic

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Journal of Hepatology|October 10, 2013
Go EastMarkus Peck-Radosavljevic
Journal of Hepatology|April 29, 2015
30 years of the Journal of Hepatology--The flagship journal and the crown-jewel of EASLMarkus Peck-Radosavljevic
Liver International : Official Journal of the International Association for the Study of the Liver|January 16, 2026
Do We Still Need a BCLC-Intermediate Stage for Hepatocellular Carcinoma-Management?Markus Peck-Radosavljevic
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2016
Thrombocytopenia in chronic liver diseaseMarkus Peck-Radosavljevic
Wiener Medizinische Wochenschrift (1946)|August 29, 2006
Portal hypertension--old problem, new therapeutic solutionsMarkus Peck-Radosavljevic
Therapeutic Advances in Gastroenterology|December 25, 2010
Hepatocellular carcinoma: the place of new medical therapiesMarkus Peck-Radosavljevic
Journal of Hepatology|July 30, 2011
Back to basics: staging and prognosis in HCC for medical oncologistMarkus Peck-Radosavljevic
Hepatology International|September 27, 2025
Long-term survival benefit of atezolizumab/bevacizumab treatment in unresectable HCC patientsMarkus Peck-Radosavljevic
Liver Cancer|June 20, 2014
Drug therapy for advanced-stage liver cancerMarkus Peck-Radosavljevic
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2009
TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect healthMarkus Peck-Radosavljevic
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Journal of Hepatology|October 10, 2013
Go EastMarkus Peck-Radosavljevic
Journal of Hepatology|April 29, 2015
30 years of the Journal of Hepatology--The flagship journal and the crown-jewel of EASLMarkus Peck-Radosavljevic
Liver International : Official Journal of the International Association for the Study of the Liver|January 16, 2026
Do We Still Need a BCLC-Intermediate Stage for Hepatocellular Carcinoma-Management?Markus Peck-Radosavljevic
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2016
Thrombocytopenia in chronic liver diseaseMarkus Peck-Radosavljevic
Wiener Medizinische Wochenschrift (1946)|August 29, 2006
Portal hypertension--old problem, new therapeutic solutionsMarkus Peck-Radosavljevic
Therapeutic Advances in Gastroenterology|December 25, 2010
Hepatocellular carcinoma: the place of new medical therapiesMarkus Peck-Radosavljevic
Journal of Hepatology|July 30, 2011
Back to basics: staging and prognosis in HCC for medical oncologistMarkus Peck-Radosavljevic
Hepatology International|September 27, 2025
Long-term survival benefit of atezolizumab/bevacizumab treatment in unresectable HCC patientsMarkus Peck-Radosavljevic
Liver Cancer|June 20, 2014
Drug therapy for advanced-stage liver cancerMarkus Peck-Radosavljevic
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2009
TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect healthMarkus Peck-Radosavljevic
Pageof 26